基本健康CAH
紐約證券 · USD
196.80
-3.05
(-1.53%)
收盤 05/30 03:59 (UTC+8)
盤後
196.40
196.40
(-0.20%)
05/30 03:59 (UTC+8)
基本健康CAH
196.80
-3.05
(-1.53%)
財務數據
損益表
- 575.58
- 550.27
- 598.67
- 522.77
- 552.64
- 548.78
- 601.59
- 640.09
- 656.27
- 609.40
- 5.10
- -4.40
- 8.80
- -12.68
- 5.71
- -0.70
- 9.62
- 6.40
- 2.53
- -7.14
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 60,940,000 | 65,627,000 | 64,009,000 | 60,159,000 | 54,878,000 | 55,264,000 | 52,277,000 | 59,867,000 | 55,027,000 | 57,558,000 |
營業成本 | 58,442,000 | 63,230,000 | 61,690,000 | 57,957,000 | 52,755,000 | 53,323,000 | 50,375,000 | 57,985,000 | 53,063,000 | 55,687,000 |
營業毛利 | 2,498,000 | 2,397,000 | 2,319,000 | 2,202,000 | 2,123,000 | 1,941,000 | 1,902,000 | 1,882,000 | 1,964,000 | 1,871,000 |
營業費用 | 1,656,000 | 1,634,000 | 1,651,000 | 1,774,000 | - | - | - | 1,481,000 | - | 1,371,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 1,542,000 | 1,504,000 | 1,461,000 | 1,484,000 | 1,315,000 | 1,306,000 | 1,277,000 | 1,277,000 | 1,308,000 | 1,294,000 |
非經常性項目費用 | - | - | 86,000 | 157,000 | -74,000 | -19,000 | -17,000 | 127,000 | 214,000 | 14,000 |
其他營業費用 | - | - | 104,000 | 133,000 | 152,000 | 105,000 | 74,000 | 77,000 | 80,000 | 63,000 |
營業利益 | 842,000 | 763,000 | 668,000 | 428,000 | 730,000 | 549,000 | 568,000 | 401,000 | 362,000 | 500,000 |
其他收入及費用 | - | - | 10,000 | 30,000 | 9,000 | -3,000 | 5,000 | -1,000 | 16,000 | 19,000 |
利息費用 | 101,000 | 88,000 | 80,000 | 74,000 | 74,000 | 35,000 | 32,000 | 9,000 | 41,000 | 11,000 |
稅前純益 | 392,000 | 630,000 | 598,000 | 384,000 | 665,000 | 511,000 | 541,000 | 391,000 | 337,000 | 508,000 |
所得稅 | 12,000 | 159,000 | 144,000 | 141,000 | 157,000 | 110,000 | 124,000 | 158,000 | 76,000 | 137,000 |
稅後純益 | 399,000 | 467,000 | 450,000 | 239,000 | 506,000 | 400,000 | 416,000 | 235,000 | 260,000 | 370,000 |
基本每股稅後盈餘(元) | 1.69 | 1.98 | 1.89 | 1.01 | 2.11 | 1.65 | 1.70 | 0.96 | 1.07 | 1.50 |
稀釋每股稅後盈餘(元) | 1.69 | 1.97 | 1.88 | 1.01 | 2.09 | 1.65 | 1.70 | 0.95 | 1.07 | 1.48 |
基本平均股數(千股) | 235000.00 | 236000.00 | 238000.00 | 239000.00 | 240000.00 | 242000.00 | 243000.00 | 244000.00 | 243000.00 | 245000.00 |
稀釋平均股數(千股) | 236000.00 | 237000.00 | 239000.00 | 240000.00 | 241000.00 | 243000.00 | 245000.00 | 245000.00 | 245000.00 | 246000.00 |
還原基本每股稅後盈餘(元) | 1.69 | 1.98 | 1.89 | 1.01 | 2.11 | 1.65 | 1.70 | 0.96 | 1.07 | 1.50 |
還原稀釋每股稅後盈餘(元) | 1.69 | 1.97 | 1.88 | 1.01 | 2.09 | 1.65 | 1.70 | 0.95 | 1.07 | 1.48 |
還原基本平均股數(千股) | 235,000 | 236,000 | 238,000 | 239,000 | 240,000 | 242,000 | 243,000 | 244,000 | 243,000 | 245,000 |
還原稀釋平均股數(千股) | 236,000 | 237,000 | 239,000 | 240,000 | 241,000 | 243,000 | 245,000 | 245,000 | 245,000 | 246,000 |
EBITDA(千元) | 760,000 | 948,000 | 907,000 | 663,000 | 944,000 | 737,000 | 754,000 | 588,000 | 554,000 | 693,000 |